Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identifying naturally-occurring active ingredients for use in skin-care products

08.04.2003


The desire for healthy-looking skin has existed throughout the centuries and has often led humanity to flowers and other plants in search of assistance. COSMACTIVE treads the same path, but uses the latest in biotechnology to identify and extract the active ingredients from a wide range of plants.



Under the umbrella of the EUREKA project COSMACTIVE, the French research company Greentech has developed a new way of identifying and selecting active ingredients that gives it, and its Spanish partner Laboratorios Dr. Vinyals, a competitive edge over their rivals.

The COSMACTIVE project looked at a variety of botanical species from countries in Africa and South America and aimed to discover the active ingredients in those plants with a view to using the plant extracts in cosmetics. The objective was to find different applications for the active compounds, using them as anti-oxidants or anti-inflammatories for example. Maria Moya from Laboratorios Dr. Vinyals, the Spanish partner in the project, explains, “we began with over 200 plants and narrowed it down to six different botanical species with some characteristic activities in genetic testing in vitro, from which we could expect good activity in vivo.”


Having identified a potentially useful molecule from one of the six starting plants, the task was to find a complementary molecule from another plant that could be combined with the first molecule to make the active ingredient in a skincare product. In this way, the active ingredient in a self-tanning cream for example, could be accurately described as an extract of the two plants.

COSMACTIVE developed two databases of information. The first, a plant database of over 17,000 species, formed the basis for identifying potential complementary ingredients. It included technical information such as botany and pharmacology, as well as the traditional, indigenous use of the plant extracts. This database was then combined with a structural chemistry database of around 12,500 molecules and with mathematical modelling software capable of simulating the behaviour of active compounds on the skin.

Three main active ingredients have been identified and the project team now has patent rights for the use of these active ingredients in the whitening creams and self-tanning products it has developed as well as an anti-inflammatory ingredient.

EUREKA proved doubly advantageous for Greentech, the project leader. “Firstly the funding, that’s very important because it allowed us to do research which we perhaps wouldn’t have been able to at that time,” explains Dr Jean-Yves Berthon, president of Greentech.

Being able to draw on the Spanish partner’s experience in biochemistry was the other advantage. “That, after all, is EUREKA’s goal, to be able to gain ‘savoir-faire’ via an industrial experiment,” says Berthon.

His company’s turnover has increased by more than 30 per cent. “The project went very well with our partner and with the EUREKA project office. It was all great!” he enthuses.

Nicola Vatthauer | alfa
Further information:
http://www.eureka.be/cosmactive

More articles from Life Sciences:

nachricht Developing a digital holography-based multimodal imaging system to visualize living cells
03.06.2020 | Kobe University

nachricht Possible physical trace of short-term memory found
03.06.2020 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

An MRI technique has been developed to improve the detection of tumors

03.06.2020 | Medical Engineering

K-State study reveals asymmetry in spin directions of galaxies

03.06.2020 | Physics and Astronomy

The cascade to criticality

03.06.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>